A detailed history of Nebula Research & Development LLC transactions in Phibro Animal Health Corp stock. As of the latest transaction made, Nebula Research & Development LLC holds 22,833 shares of PAHC stock, worth $858,977. This represents 0.05% of its overall portfolio holdings.

Number of Shares
22,833
Previous 20,094 13.63%
Holding current value
$858,977
Previous $429 Million 35.87%
% of portfolio
0.05%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$16.53 - $25.66 $45,275 - $70,282
2,739 Added 13.63%
22,833 $583 Million
Q1 2025

May 15, 2025

BUY
$20.05 - $26.22 $202,144 - $264,350
10,082 Added 100.7%
20,094 $429 Million
Q4 2024

Feb 14, 2025

BUY
$20.89 - $25.55 $209,150 - $255,806
10,012 New
10,012 $210 Million
Q4 2023

Feb 14, 2024

BUY
$9.59 - $12.91 $203,509 - $273,963
21,221 New
21,221 $246 Million

Others Institutions Holding PAHC

About PHIBRO ANIMAL HEALTH CORP


  • Ticker PAHC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 20,337,600
  • Market Cap $765M
  • Description
  • Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...
More about PAHC
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.